tirzepatide and osteoporosis Tirzepatide, a dual GLP-1 GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Tirzepatide and Bone Density |

We disclose any warnings relating to allergen exposure beneath the supplement facts in the ingredients listing on the product label

Secondary benefits include support for healthy blood glucose levels, improved insulin sensitivity, and enhanced metabolic efficiency

Audio Commentary by Dr Katrina Pears ME/CFS Research Published 13 20 February 2023 Its been a comparatively quiet week for ME/CFS research, with four new ME/CFS studies but seventeen new Long Covid studies

Studies have noted that vagotomy can inhibit the misfolding of alpha-synuclein in enteric neurons and reduce the appearance of PD symptoms in animal models (Uemura et al., 2018